Cargando…

Class II HLA genotype in fulminant type 1 diabetes: A nationwide survey with reference to glutamic acid decarboxylase antibodies

Aims/Introduction: Fulminant type 1 diabetes is a subtype of type 1 diabetes characterized by a remarkably abrupt onset of insulin‐deficient hyperglycemia within a few days. The aim of the present study was to clarify characteristic class II HLA genotypes in a large number of patients with fulminan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsutsumi, Chiharu, Imagawa, Akihisa, Ikegami, Hiroshi, Makino, Hideichi, Kobayashi, Tetsuro, Hanafusa, Toshiaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2011
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4014934/ https://www.ncbi.nlm.nih.gov/pubmed/24843547 http://dx.doi.org/10.1111/j.2040-1124.2011.00139.x

Ejemplares similares

Report of the Committee of the Japan Diabetes Society on the Research of Fulminant and Acute‐onset Type 1 Diabetes Mellitus: New diagnostic criteria of fulminant type 1 diabetes mellitus (2012)
por: Imagawa, Akihisa, et al.
Publicado: (2012)

Differences in the Contribution of the CTLA4 Gene to Susceptibility to Fulminant and Type 1A Diabetes in Japanese Patients
por: Kawasaki, Eiji, et al.
Publicado: (2008)

Type 1 Diabetes and Interferon Therapy: A nationwide survey in Japan
por: Nakamura, Kan, et al.
Publicado: (2011)

Clinical and Genetic Characteristics of Non-Insulin-Requiring Glutamic Acid Decarboxylase (GAD) Autoantibody-Positive Diabetes: A Nationwide Survey in Japan
por: Yasui, Junichi, et al.
Publicado: (2016)

Diagnostic criteria for acute‐onset type 1 diabetes mellitus (2012): Report of the Committee of Japan Diabetes Society on the Research of Fulminant and Acute‐onset Type 1 Diabetes Mellitus
por: Kawasaki, Eiji, et al.
Publicado: (2014)

Correlation of glycated albumin but not hemoglobin A(1c) with endogenous insulin secretion in fulminant type 1 diabetes mellitus
por: Koga, Masafumi, et al.
Publicado: (2010)

Pathogenesis of fulminant type 1 diabetes: Genes, viruses and the immune mechanism, and usefulness of patient‐derived induced pluripotent stem cells for future research
por: Hosokawa, Yoshiya, et al.
Publicado: (2019)

Endogenous insulin secretion even at a very low level contributes to the stability of blood glucose control in fulminant type 1 diabetes
por: Shibasaki, Saeko, et al.
Publicado: (2010)

Antibody to CMRF35-Like Molecule 2, CD300e A Novel Biomarker Detected in Patients with Fulminant Type 1 Diabetes
por: Haseda, Fumitaka, et al.
Publicado: (2016)

Fulminant Type 1 Diabetes as a Model of Nature to Explore the Role of C-Peptide
por: Murase-Mishiba, Yuko, et al.
Publicado: (2008)

Two types of fulminant type 1 diabetes mellitus: Immune checkpoint inhibitor‐related and conventional
por: Imagawa, Akihisa
Publicado: (2020)

Re-Enlightenment of Fulminant Type 1 Diabetes under the COVID-19 Pandemic
por: Sano, Hiroyuki, et al.
Publicado: (2022)

“Preserved” glucagon secretion in fulminant type 1 diabetes
por: Murase‐Mishiba, Yuko, et al.
Publicado: (2018)

Zinc transporter 8 autoantibodies complement glutamic acid decarboxylase and insulinoma‐associated antigen‐2 autoantibodies in the identification and characterization of Japanese type 1 diabetes
por: Kawasaki, Eiji, et al.
Publicado: (2020)

Possible Contribution of Taurine to Distorted Glucagon Secretion in Intra-Islet Insulin Deficiency: A Metabolome Analysis Using a Novel α-Cell Model of Insulin-Deficient Diabetes
por: Bessho, Megumi, et al.
Publicado: (2014)

Three Distinct Glutamate Decarboxylase Genes in Vertebrates
por: Grone, Brian P., et al.
Publicado: (2016)

Molecular Analysis of Glutamate Decarboxylases in Enterococcus avium
por: Gu, Xinyi, et al.
Publicado: (2021)

Neurological Disorders Associated with Glutamic Acid Decarboxylase Antibodies
por: Herard, Kimberly, et al.
Publicado: (2019)

Parallel Strategy Increases the Thermostability and Activity of Glutamate Decarboxylase
por: Zhang, Qing-Fei, et al.
Publicado: (2020)

Cytotoxic T cells specific for glutamic acid decarboxylase in autoimmune diabetes
Publicado: (1995)

Calmodulin-dependent and calmodulin-independent glutamate decarboxylases in apple fruit
por: Trobacher, Christopher P, et al.
Publicado: (2013)

Anti-glutamic acid decarboxylase antibody positive neurological syndromes
por: Tohid, Hassaan
Publicado: (2016)

Neurological Manifestations of Glutamic Acid Decarboxylase Autoimmunity in Indian Patients
por: Thevarkalam, Meena, et al.
Publicado: (2023)

Normal Incidence of Diabetes in NOD Mice Tolerant to Glutamic Acid Decarboxylase
por: Jaeckel, Elmar, et al.
Publicado: (2003)

Limbic encephalitis with antibodies to glutamic acid decarboxylase presenting with brainstem symptoms
por: Incecik, Faruk, et al.
Publicado: (2015)

Identification and molecular cloning of glutamate decarboxylase gene from Lactobacillus casei
por: Tavakoli, Yasaman, et al.
Publicado: (2015)

Increased glutamic acid decarboxylase expression in the hypothalamic suprachiasmatic nucleus in depression
por: Wu, Xueyan, et al.
Publicado: (2017)

Hippocampus and Insula Are Targets in Epileptic Patients With Glutamic Acid Decarboxylase Antibodies
por: Falip, Mercè, et al.
Publicado: (2019)

Pathogenic Roles of Glutamic Acid Decarboxylase 65 Autoantibodies in Cerebellar Ataxias
por: Mitoma, Hiroshi, et al.
Publicado: (2017)

Global knockdown of glutamate decarboxylase 67 elicits emotional abnormality in mice
por: Miyata, Shigeo, et al.
Publicado: (2021)

Association of HLA Genotype and Fulminant Type 1 Diabetes in Koreans
por: Kwak, Soo Heon, et al.
Publicado: (2015)

Contribution of glutamate decarboxylase in Lactobacillus reuteri to acid resistance and persistence in sourdough fermentation
por: Su, Marcia S, et al.
Publicado: (2011)

Respective implications of glutamate decarboxylase antibodies in stiff person syndrome and cerebellar ataxia
por: Manto, Mario U, et al.
Publicado: (2011)

Glutamate decarboxylase 67 contributes to compensatory insulin secretion in aged pancreatic islets
por: Cho, Jung Hoon, et al.
Publicado: (2019)

Glutamic acid decarboxylase antibodies in neurocritical patients: a culprit or a bystander?
por: Wang, Dongmei, et al.
Publicado: (2020)

Epilepsy in patients with insulin-dependent diabetes and relation to glutamic acid decarboxylase 65
por: Mahmoud, Adel A., et al.
Publicado: (2020)

The clinical relevance of anti-glutamic acid decarboxylase antibodies in children with encephalitis/encephalopathy
por: Hou, Ju-Yin, et al.
Publicado: (2023)

Glutamate decarboxylase 1 gene polymorphisms are associated with respiratory symptoms in panic disorder
por: Zou, Zhi-Li, et al.
Publicado: (2023)

Comparing the clinical significance and antigen specificity of insulinoma‐associated antigen‐2 autoantibodies between radioimmunoassay and enzyme‐linked immunosorbent assay in Japanese patients with type 1 diabetes
por: Kawasaki, Eiji, et al.
Publicado: (2022)

Bivalent GAD autoantibody ELISA improves clinical utility and risk prediction for adult autoimmune diabetes
por: Kawasaki, Eiji, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tgi7tfjgqf4v0me8g942vp35ra